Management of Tachycardia in a Patient with Infected Pilonidal Cyst
The tachycardia at 117 bpm in this patient with an infected pilonidal cyst represents a physiologic response to infection and should be managed by treating the underlying infection with incision and drainage plus antibiotics, rather than treating the tachycardia itself. 1, 2
Understanding the Tachycardia
- Sinus tachycardia in this context is a physiologic response to infection, representing one component of systemic inflammatory response syndrome (SIRS). 1, 2
- The heart rate of 117 bpm meets SIRS criteria (tachycardia >90 bpm) and indicates the body's response to the infectious process. 2
- Pathological causes of sinus tachycardia include pyrexia, hypovolemia, and infections—all potentially present with an infected pilonidal abscess. 1
- This tachycardia requires evaluation for the underlying stressor (infection) rather than direct rate control. 1
Primary Management: Treat the Infection
Immediate Surgical Management
- Incision and drainage is the cornerstone of treatment for inflamed pilonidal cysts and abscesses. 2, 3
- The presence of SIRS criteria (including this tachycardia) mandates the addition of systemic antibiotics to surgical drainage. 2
- Thorough evacuation of pus and probing the cavity to break up loculations is essential for complete drainage. 3
- Simply covering the surgical site with a dry dressing after drainage is the most effective wound treatment. 3
Antibiotic Selection
- Cephalexin 500 mg orally four times daily for 5-7 days is the appropriate first-line empiric therapy for purulent drainage with SIRS criteria. 2
- Alternative options if cephalexin is unsuitable include clindamycin 300-450 mg orally three times daily plus trimethoprim-sulfamethoxazole (1-2 double-strength tablets twice daily). 2
- For perineum/sacrococcygeal infections, cefoxitin and ampicillin-sulbactam are also effective options. 2
- Gram stain and culture of pus should be obtained to guide antibiotic therapy. 2
When to Address the Tachycardia Directly
- The tachycardia should resolve as the infection is treated and does not require specific cardiac intervention unless the patient becomes hemodynamically unstable. 1
- If the patient develops hemodynamic instability (hypotension, altered mental status, chest pain, acute heart failure), then the tachycardia itself requires immediate management. 1
- For stable patients with sinus tachycardia, direct treatment of the arrhythmia is not indicated—only treatment of the underlying cause. 1
Monitoring Parameters
- Reassess vital signs after adequate drainage and initiation of antibiotics; the heart rate should trend downward as the infection is controlled. 2
- Check for other SIRS criteria: temperature >38°C or <36°C, tachypnea >24 breaths/minute, white blood cell count >12,000 or <4,000 cells/µL. 2, 3
- If tachycardia persists despite adequate source control, evaluate for complications such as inadequate drainage, abscess recurrence, or other concurrent pathology. 3
Common Pitfalls to Avoid
- Do not treat the tachycardia with rate-controlling medications (beta-blockers, calcium channel blockers) when it represents a physiologic response to infection. 1
- Failure to properly drain the abscess is the most common reason for treatment failure, not antibiotic selection—inadequate drainage will perpetuate the infection and tachycardia. 2
- Do not assume the tachycardia is benign without ensuring adequate source control through proper incision and drainage. 2, 3
- Avoid closing the wound or inadequate probing of the cavity, as incomplete drainage leads to persistent infection and ongoing systemic response. 3
Expected Clinical Course
- Most patients return to work 7-10 days after treatment, and the tachycardia should resolve within 24-48 hours of adequate drainage and antibiotic initiation. 4, 5
- If the heart rate does not improve after proper source control, consider re-evaluation for incomplete drainage or alternative diagnoses. 3
- Duration of antibiotic therapy is typically 5-7 days for uncomplicated cases, with extension to 10-14 days for more severe infections based on clinical response. 2